BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 22348942)

  • 1. Probing protein phosphatase substrate binding: affinity pull-down of ILKAP phosphatase 2C with phosphopeptides.
    Højlys-Larsen KB; Sørensen KK; Jensen KJ; Gammeltoft S
    Mol Biosyst; 2012 Apr; 8(5):1452-60. PubMed ID: 22348942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Wip1 phosphatase PPM1D dephosphorylates SQ/TQ motifs in checkpoint substrates phosphorylated by PI3K-like kinases.
    Yamaguchi H; Durell SR; Chatterjee DK; Anderson CW; Appella E
    Biochemistry; 2007 Nov; 46(44):12594-603. PubMed ID: 17939684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arsenic trioxide augments Chk2/p53-mediated apoptosis by inhibiting oncogenic Wip1 phosphatase.
    Yoda A; Toyoshima K; Watanabe Y; Onishi N; Hazaka Y; Tsukuda Y; Tsukada J; Kondo T; Tanaka Y; Minami Y
    J Biol Chem; 2008 Jul; 283(27):18969-79. PubMed ID: 18482988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wip1 phosphatase modulates ATM-dependent signaling pathways.
    Shreeram S; Demidov ON; Hee WK; Yamaguchi H; Onishi N; Kek C; Timofeev ON; Dudgeon C; Fornace AJ; Anderson CW; Minami Y; Appella E; Bulavin DV
    Mol Cell; 2006 Sep; 23(5):757-64. PubMed ID: 16949371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of ATM/p53-dependent suppression of myc-induced lymphomas by Wip1 phosphatase.
    Shreeram S; Hee WK; Demidov ON; Kek C; Yamaguchi H; Fornace AJ; Anderson CW; Appella E; Bulavin DV
    J Exp Med; 2006 Dec; 203(13):2793-9. PubMed ID: 17158963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PPM1D dephosphorylates Chk1 and p53 and abrogates cell cycle checkpoints.
    Lu X; Nannenga B; Donehower LA
    Genes Dev; 2005 May; 19(10):1162-74. PubMed ID: 15870257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of nuclear localization signal in the N terminus of integrin-linked kinase-associated phosphatase (ILKAP) and its essential role in the down-regulation of RSK2 protein signaling.
    Zhou W; Cao H; Yang X; Cong K; Wang W; Chen T; Yin H; Wu Z; Cai X; Liu T; Xiao J
    J Biol Chem; 2013 Mar; 288(9):6259-71. PubMed ID: 23329845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On-bead chemical synthesis and display of phosphopeptides for affinity pull-down proteomics.
    Brandt M; Madsen JC; Bunkenborg J; Jensen ON; Gammeltoft S; Jensen KJ
    Chembiochem; 2006 Apr; 7(4):623-30. PubMed ID: 16502475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of integrin signal transduction by ILKAP, a protein phosphatase 2C associating with the integrin-linked kinase, ILK1.
    Leung-Hagesteijn C; Mahendra A; Naruszewicz I; Hannigan GE
    EMBO J; 2001 May; 20(9):2160-70. PubMed ID: 11331582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a substrate-based cyclic phosphopeptide inhibitor of protein phosphatase 2Cdelta, Wip1.
    Yamaguchi H; Durell SR; Feng H; Bai Y; Anderson CW; Appella E
    Biochemistry; 2006 Nov; 45(44):13193-202. PubMed ID: 17073441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical characterization and deletion analysis of recombinant human protein phosphatase 2C alpha.
    Marley AE; Sullivan JE; Carling D; Abbott WM; Smith GJ; Taylor IW; Carey F; Beri RK
    Biochem J; 1996 Dec; 320 ( Pt 3)(Pt 3):801-6. PubMed ID: 9003365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substrate specificity of Ca(2+)/calmodulin-dependent protein kinase phosphatase: kinetic studies using synthetic phosphopeptides as model substrates.
    Ishida A; Shigeri Y; Tatsu Y; Endo Y; Kameshita I; Okuno S; Kitani T; Takeuchi M; Yumoto N; Fujisawa H
    J Biochem; 2001 May; 129(5):745-53. PubMed ID: 11328597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p90 ribosomal S6 kinase 2 is associated with and dephosphorylated by protein phosphatase 2Cdelta.
    Doehn U; Gammeltoft S; Shen SH; Jensen CJ
    Biochem J; 2004 Sep; 382(Pt 2):425-31. PubMed ID: 15206906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional.
    Lossaint G; Besnard E; Fisher D; Piette J; Dulić V
    Oncogene; 2011 Oct; 30(41):4261-74. PubMed ID: 21532626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dephosphorylation of phosphopeptides by calcineurin (protein phosphatase 2B).
    Donella-Deana A; Krinks MH; Ruzzene M; Klee C; Pinna LA
    Eur J Biochem; 1994 Jan; 219(1-2):109-17. PubMed ID: 7508382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resveratrol causes Cdc2-tyr15 phosphorylation via ATM/ATR-Chk1/2-Cdc25C pathway as a central mechanism for S phase arrest in human ovarian carcinoma Ovcar-3 cells.
    Tyagi A; Singh RP; Agarwal C; Siriwardana S; Sclafani RA; Agarwal R
    Carcinogenesis; 2005 Nov; 26(11):1978-87. PubMed ID: 15975956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmented cancer resistance and DNA damage response phenotypes in PPM1D null mice.
    Nannenga B; Lu X; Dumble M; Van Maanen M; Nguyen TA; Sutton R; Kumar TR; Donehower LA
    Mol Carcinog; 2006 Aug; 45(8):594-604. PubMed ID: 16652371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Wip1 phosphatase (PPM1D) antagonizes activation of the Chk2 tumour suppressor kinase.
    Oliva-Trastoy M; Berthonaud V; Chevalier A; Ducrot C; Marsolier-Kergoat MC; Mann C; Leteurtre F
    Oncogene; 2007 Mar; 26(10):1449-58. PubMed ID: 16936775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilizing protein phosphatase inhibitors to define PP2A as a regulator of ataxia-telangiectasia mutated.
    Goodarzi AA; Douglas P; Moorhead GB; Lees-Miller SP
    Methods Mol Biol; 2007; 365():47-59. PubMed ID: 17200553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Wip1 Phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory loop.
    Lu X; Ma O; Nguyen TA; Jones SN; Oren M; Donehower LA
    Cancer Cell; 2007 Oct; 12(4):342-54. PubMed ID: 17936559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.